蒙特卢卡斯特在患有喘的儿科患者开始治疗后的神经精神病诊断
Tapio Paljarvi1, Julian T Forton2,3, Courtney Thompson4
1Niuvanniemi Hospital, Kuopio, Finland tapio.paljarvi@niuva.fi.
Thorax
|November 22, 2024
概括
蒙特卢卡斯特作为儿童和青少年 (CYP) 喘治疗的补充剂与神经精神病诊断的增加有关. 这包括睡眠,焦虑和情绪障碍,突出了这个年龄组的潜在风险.
科学领域:
- 儿科肺病学 儿科肺病学
- 儿童和青少年精神病学 儿童和青少年精神病学
- 药物监督 药物监督 药物监督
背景情况:
- 关于蒙特卢卡斯特对患有喘的儿童和青少年 (CYP) 的不良影响的证据是不确定的.
- 蒙特卢卡斯特经常被用作吸入性皮质类固醇 (ICS) 的辅助疗法.
研究的目的:
- 为了调查在喘时的CYP中蒙特卢卡斯特启动后的一年神经精神病诊断的发生率.
- 评估蒙特卢卡斯特使用与儿科喘患者神经心理结局之间的关联.
主要方法:
- 一项使用美国电子健康记录 (2015-2019) 的倾向分数匹配队列研究.
- 使用ICD-10-CM代码识别的神经精神病诊断.
- 计算的风险比率 (RRs),绝对风险增加 (ARI) 和伤害所需数量 (NNH).
主要成果:
- 蒙特卢卡斯特的使用与任何神经精神病结局的发病率更高有关 (RR 1.32).
- 睡眠障碍的过度风险最高 (RR 1.63),其次是焦虑和情绪障碍 (RR 1.16).
- 对于任何神经精神病的结果,需要伤害的1年人数 (NNH) 是58名患者.
结论:
- 在ICS上,CYP与喘的辅助蒙特卢卡斯特治疗与神经精神病结局的增加有关.
- 研究结果表明,蒙特卢卡斯特与儿科喘患者的不良神经精神事件之间存在潜在的关联.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
351
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
351
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K


